Nutrition issues in cystic fibrosis

Practical Gastroenterology

Volumn 29, Issue 5, 2005, Pages 76-94

  Goodin, Barbara ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APPETITE STIMULANT; CHLORIDE; CREON 10; CREON 20; CREON 5; CYPROHEPTADINE; HISTAMINE H2 RECEPTOR ANTAGONIST; MEGESTROL ACETATE; PANCREACARB MS16; PANCREACARB MS4; PANCREACARB MS8; PANCREAS ENZYME; PANCREASEMT10; PANCREASEMT16; PANCREASEMT20; PANCREASEMT4; PANCRELIPASE; PROTON PUMP INHIBITOR; RETINOL; TRIACYLGLYCEROL LIPASE; ULTRASEMT12; ULTRASEMT18; ULTRASEMT20; VITAMIN D; VITAMIN K GROUP;

CYSTIC FIBROSIS; DIABETES MELLITUS; HUMAN; LUNG FUNCTION; NUTRITION; PANCREAS FUNCTION; PRACTICE GUIDELINE; REVIEW; SWEAT TEST; VITAMIN SUPPLEMENTATION;

EID: 20444369823     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Hamosh A, FitzSimmons SC, Macek M Jr, et al. Comparison of the clinical manifestations of cystic fibrosis in African-American and Caucasiens. J Pediatr, 1998;132(2):255-259.
2. Cystic Fibrosis Foundation. Report of the 1995 Patient Registry. Bethesda, Maryland.
3. Cystic Fibrosis Foundation. Consensus Conferences: The Diagnosis of cystic fibrosis consensus statement. 1996. Bethesda Maryland.
4. Yankaskas JR, Marshall BC, Sufian B, et al. Cystic Fibrosis Adult Care* consensus Conference Report. Chest, 2004;125:1S-39S.
5. Sharma R, Florea VG, Bolger AP, Doehner W, et al. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax, 2001;56:746-750.
6. Steinkamp G, von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr, 1994;124:244-249.
7. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival. Growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol, 1988;41:583-591.
8. Cystic Fibrosis Foundation Patient Registry. Annual Data Report 2003. Bethesda, Maryland.
9. Zemel VS, Jawad AE, FitzSimmons S, et al. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr, 2000;137:374-380.
10. Kraemer R, Rudeberg A, Hadorn B. Relative underweight in cystic fibrosis and its prognostic value. Acta Peadiatr Scand, 1978;67:33-37.
11. Beker LT, Russek-Cohen E, et al. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc, 2001;101:438-442.
12. Snell GI, Bennetts K, Bartolo J, et al. Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transpl, 1998;17:1097-2003.
13. Metropolitan Life Insurance Company. Statistical Bulletin, 1983;64:2-9.
14. Cystic Fibrosis Foundation. Clinical practice guidelines for cystic fibrosis. Bethesda, MD: Cystic Fibrosis Foundation, 1997.
15. Borowitz D. Baker RD, Stallings V. Consensus report on pediatric nutrition for patients with cystic fibrosis. J Ped Gastro Nutr, 2002;35(3):246-259.
16. Welsh, MJ, Tsui LC, Boat TF, et al. Cystic fibrosis, In: Scriver CR, Beaudet AL, Sly WS, et al. Eds. The Metabolic and Molecular Basis of inherited Disease, 7th ed. Vol. 3. New York: McGraw-Hill, 1995:3799-3876.
17. Durno C, Corey M, Zielenski J, et al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology, 2002;123:1857-1864.
18. Borowitz, D. Pediatric Pulmonology, 2000;29:167-168.
19. Leus J, van Biervliet S, Robberecht E. Detection and follow-up of exocrine pancreatic insufficiency in cystic fibrosis: a review. Eur J Pediatr, 2000;159:563-568.
20. Borowitz D, Baker SS, Duffy L, et al. Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr, 2004;145:322-326.
21. Graziano GL, Babbini L, Battistini S, Lazzari R, Pezzilli R. Faecal elastase-1 in children with cystic fibrosis. Euro J Pediatr, 1997;156(10):770-772.
22. Littlewood JM. Abdominal pain in cystic fibrosis. J Soc Med, 1995;88:9-17.
23. FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammeistrom T, Durie PR, Lloyd-Still JD, Lowenfels AB. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. NEJM, 1997;336:1283-1289.
24. Borowitz DS, Grand RJ, Durie, PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr, 1995;127(5):681-684.
25. Symonds EL, Omari TI, Webster JM, et al. Relation between pancreatic lipase activity and gastric emptying rate in children with cystic fibrosis. J Pediatar, 2003;143:772-775.
26. Easley D, Krebs N, Jefferson M, et al. Effect of pancreatic enzymes on zinc absorption in cystic fibrosis. J Pediatr Gastroenterol Nutr, 1998;26:136-139.
27. Krebs NF, Westcott JE, Arnold TD, et al. Abnormalities in zinc homeostasis in young infants with cystic fibrosis. Ped Res, 2000;48(2):256-261.
28. Palin D, Underwood BA, Denning CR. The effect of oral zinc supplementation on plasma levels of vitamin A and retinol-binding protein in cystic fibrosis. Am J Clin Nutr, 1979;32:1253-1259.
29. Nasir SZ, O'Leary H, Hillermeier C. Correction of vitamin E deficiency with fat-soluble versus water-miscible preparations of vitamin E in patients with cystic fibrosis. J Pediatr, 1993;122:810-812.
30. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Food and Nutrition Board. Institute of Medicine. National Academy Press, Washington, DC, 2001.
31. Eubanks V, Koppersmith N, Wooldridge N, et al. Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis. J Pediatr, 2002;140:439-444.
32. Marchand V, Baker SS, Stark TJ, et al. Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis. J Pediatr Gastroenterol Nutr, 2000;31(3):264-269.
33. Nasr SZ, Hurwitz ME, Brown RW, et al. Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis. Pediatr Pulmonol, 1999;28:380-382.
34. McKone EF, Tonelli MR, Aitken ML. Adrenal insufficiency and testicular failure secondary to megestrol acetate therapy in a patient with cystic fibrosis. Pediatr Pulmonol, 2002;34:381-383.
35. Homnick DN, Homnick BD, Reeves AJ, et al. Cyproheptadine is an effective appetite stimulant in cystic fibrosis. Pediatr Pulmonol, 2004;38:129-134.
36. Erskine JM, Lingard CD, Sontag MK, et al. Enteral nutrition for patients with cystic fibrosis: Comparison of a semi-elemental and nonelemental formula. J Pediatr, 1998;132:265-269.
37. Moran A, Hardin D, Rodman D, et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report. Diabetes Res Clin Pract, 1999;45(1): 61-73.